Victoria Park Medispa
Westmount, Quebec, H3Z1C3, Canada
NCT Number: NCT03584347
Objectives
1. Evaluate the ability of aesthetic physicians to accurately inject a specific amount (i.e., 0.2cc) of HA soft tissue filler; and 2. Investigate the effect of different HA gel properties (e.g., G', cohesivity, viscoelasticity) on an injector's performance accuracy.
Looking for future studies?
Notify Me21 year–80 year
All sexes
Interventional
Not applicable
Westmount, Quebec, H3Z1C3, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will be blind folded and asked to deposit 0.2cc's of each of the four investigational products, in a randomized order. First, over a weight and then into a porcine membrane.
Time frame: Baseline
physicians will attempt to inject 0.2CC of four HA products into a porcine membrane. Volumes will be measured in CC's and their accuracy assessed based on the amount of product left in the syringe.
Time frame: Baseline
Physicians will attempt to dispense 0.2CC of four different HA products. They will do this into free air, over a scale. The weights will be calculated in grams and converted to CC's. The scale is the "Smart Weight" digital milligram scale, JDS20 edition. It's specifications are as follows: capacity: 20g/100ct/308.8gn/12.86dwt; readability: 0.001g/0.005ct/0.02gn/0.001dwt; scale dimensions: 3x5x0.8"; accuracy of 0.001grams and capacity of 20grams.
Erevna Innovations Inc.
Other
Evaluation of Physician Volumetric Accuracy During Hyaluronic Acid Soft Tissue Filler Injections and the Effect of Products' Biophysical Properties on an Injector's Performance: An Observational, Proof-of-concept Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05296187
Injection Site
Konya, Turkey (Türkiye)
View Trial DetailsNCT04311099
Abdominal Pain, Agnosia
Esbjerg, Denmark
View Trial DetailsNCT07063160
Behavior, Iatrophobia
Mersin, - Please Select -, Turkey (Türkiye)
View Trial DetailsNCT06840353
Injection Site, Neurologic Manifestations
Konya, Turkey (Türkiye)
View Trial Details